Vital Signs to Monitor During a Ketamine Troche Session

For most prescriber-supervised ketamine troche protocols, the vital signs to track are blood pressure and heart rate, checked once before you place the troche (your baseline) and again near peak effect, which typically falls somewhere between 20 and 60 minutes after dosing. A ketamine troche is a compounded lozenge dissolved between the cheek and gum or under the tongue, letting ketamine absorb through the oral mucosa rather than being swallowed. Because ketamine can cause a short-lived rise in blood pressure and heart rate, your prescriber sets an individual threshold for you and tells you what to do if you cross it.

This article covers what to check, when to check it, and what readings should prompt you to contact your prescriber. It's educational information, not a substitute for your prescriber's specific instructions. Compounded ketamine troches are prescribed off-label and are not an FDA-approved product; only esketamine nasal spray (Spravato) carries FDA approval, and only for treatment-resistant depression.

Why blood pressure and heart rate matter most

Ketamine is an NMDA (N-methyl-D-aspartate) receptor antagonist, a drug class that blocks a specific glutamate receptor involved in pain signaling and mood. Across intravenous and intranasal ketamine studies, the most consistently reported physical effect is a transient rise in blood pressure and heart rate that peaks early and fades as the dissociative effects wear off. The FDA-approved label for esketamine (Spravato) directs clinics to monitor blood pressure at baseline and at roughly 40 minutes post-dose during in-office administration, reflecting that same early monitoring window.

Sublingual and buccal troches reach lower peak blood levels than intravenous or intranasal ketamine, and published data on vital-sign changes specific to compounded troches is limited. That's one reason prescribers still ask for the same before-and-after checks used in better-studied routes: it's a cautious baseline, not proof that troches carry an identical cardiovascular effect. Learn more about how to check blood pressure before a troche session and how timing fits into the full onset, peak, and duration timeline for troches.

What else to watch, beyond the numbers

Vital signs are only part of the picture. Dissociation, the sense of feeling detached from your body or surroundings, is an expected effect of ketamine and usually isn't itself a danger sign. What matters is whether it's severe enough to interfere with your ability to check your own readings or respond to a check-in from the person supervising your session. Severe or worsening anxiety, chest pain, difficulty breathing, or confusion that doesn't improve as the session winds down are reasons to stop and contact your prescriber or seek urgent care, regardless of what the numbers say.

Building monitoring into your session routine

Where you place the troche and how you time your dose both affect how useful your readings are. Using proper buccal ketamine technique, holding the lozenge against the cheek without chewing or swallowing, helps keep absorption consistent, which makes session-to-session vital sign comparisons more meaningful. Pairing that with a steady routine, covered in more detail in guides on timing your troche sessions, makes it easier to spot a reading that's actually unusual rather than normal session-to-session variation.

Bring your logged readings to your next visit. Guides on questions to ask at a troche follow-up appointment can help you turn a few weeks of vital sign data into a useful conversation about whether your dose, timing, or monitoring routine needs to change.